TD Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-107,554
Closed -$8.63M 1463
2016
Q4
$8.63M Sell
107,554
-20,952
-16% -$1.66M 0.01% 557
2016
Q3
$10.3M Sell
128,506
-1,506
-1% -$122K 0.02% 522
2016
Q2
$10.1M Buy
130,012
+9,980
+8% +$712K 0.02% 506
2016
Q1
$6.6M Sell
120,032
-7,107
-6% -$387K 0.01% 594
2015
Q4
$7.85M Buy
127,139
+2,700
+2% +$170K 0.02% 539
2015
Q3
$7.85M Buy
124,439
+300
+0.2% +$21.4K 0.02% 518
2015
Q2
$9.07M Buy
124,139
+350
+0.3% +$25.3K 0.02% 532
2015
Q1
$8.1M Sell
123,789
-52,708
-30% -$3.5M 0.01% 552
2014
Q4
$11.5M Sell
176,497
-14,256
-7% -$918K 0.02% 454
2014
Q3
$11.5M Sell
190,753
-28,170
-13% -$1.84M 0.02% 438
2014
Q2
$15.2M Sell
218,923
-21,600
-9% -$1.4M 0.03% 384
2014
Q1
$15.7M Sell
240,523
-1,800
-0.7% -$117K 0.03% 373
2013
Q4
$15M Buy
242,323
+48,200
+25% +$2.79M 0.03% 369
2013
Q3
$10.4M Sell
194,123
-4,300
-2% -$221K 0.02% 422
2013
Q2
$9.05M Buy
+198,423
New +$8.6M 0.02% 434

Other funds holding STJ

TD Asset Management's STJ Position: Q1 2017 in Review

TD Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 107,554 shares — an estimated $8.63M sold.

TD Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $15.7M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • TD Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • TD Asset Management sold 107,554 St Jude Medical shares in Q1 2017, an estimated $8.63M.
  • TD Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • TD Asset Management's St Jude Medical position peaked at $15.7M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on TD Asset Management's 13F filing for Q1 2017, filed 5 May 2017.